Author/year | Population/study | Anxiety disorder | Prevalence of comorbid MDD |
Schneier et al. 1992[1] | ECA | SAD | 16.6% (lifetime) |
Flint 1994[2] | ECA | All anxiety disorders | 21% (12-month) |
GAD | 60% (12-month) | ||
Wittchen et al. 1994[3] | NCS | GAD | 38.6% (30 day GAD); 62.4% (lifetime) |
Kessler et al. 1995[4] | NCS | PTSD | 47.9% (males, lifetime); 48.5% (females, lifetime) |
Magee et al. 1996[5] | NCS | SAD | 37.2% (lifetime) |
AGOR | 45.9% (lifetime) | ||
SP | 42.3% (lifetime) | ||
Kessler et al. 1999[6] | NCS | GAD | 58.1% (12-month) |
MDUSS | 69.7% (12-month) | ||
Lieb et al. 2005[7] | ESEMeD | GAD | 59% (12-month) |
Alonso et al. 2007[8] | ESEMeD | SAD | 14.5% (all 12-month) |
GAD | 37.1% | ||
PTSD | 7.8% | ||
PD | 29.8% | ||
AGOR | 15.5% | ||
SP | 15.5% | ||
Eisenberg et al. 2007[9] | WHO, WMHS | GAD | 30.4% (2 weeks) |
PD | 9.4% (2 weeks) | ||
Gabilondo et al. 2010[10] | ESEMeD | SAD | 7.7% (all 12-month) |
GAD | 15% | ||
PTSD | 7.3% | ||
PD | 9% | ||
AGOR | 3% | ||
SP | 14.4% | ||
Kessler et al. 2010[11] | WHO, WMHS | Any anxiety disorder | 49.7% (12-month) |
Ruscio et al. 2010[12] | NCS-R | OCD | 40.7% (lifetime) |
Kessler et al. 2015[13] | WHO, WMHS | Any anxiety disorder | 45.7% (lifetime) |
Any anxiety disorder | 41.6% (12-month) | ||
Adams et al. 2016[14] | CPES | Any anxiety disorder (except SAD) | 3.71% (lifetime) |
Any anxiety disorder (≥2) | 7.43% (lifetime) |
Do you want to add Medilib to your home screen?